nodes	percent_of_prediction	percent_of_DWPC	metapath
Penicillamine—L-Cysteine—MGMT—malignant glioma	0.0667	1	CrCbGaD
Penicillamine—Pulmonary fibrosis—Carmustine—malignant glioma	0.0482	0.0516	CcSEcCtD
Penicillamine—Pulmonary fibrosis—Temozolomide—malignant glioma	0.0465	0.0499	CcSEcCtD
Penicillamine—Interstitial pneumonia—Temozolomide—malignant glioma	0.0424	0.0454	CcSEcCtD
Penicillamine—Interstitial lung disease—Carmustine—malignant glioma	0.0299	0.0321	CcSEcCtD
Penicillamine—Interstitial lung disease—Temozolomide—malignant glioma	0.0289	0.031	CcSEcCtD
Penicillamine—Cholestasis—Temozolomide—malignant glioma	0.027	0.0289	CcSEcCtD
Penicillamine—Coagulopathy—Temozolomide—malignant glioma	0.0263	0.0282	CcSEcCtD
Penicillamine—Extravasation—Carmustine—malignant glioma	0.0243	0.026	CcSEcCtD
Penicillamine—Leukocytosis—Carmustine—malignant glioma	0.0225	0.0241	CcSEcCtD
Penicillamine—Neuropathy—Carmustine—malignant glioma	0.0199	0.0213	CcSEcCtD
Penicillamine—Aplastic anaemia—Temozolomide—malignant glioma	0.0192	0.0206	CcSEcCtD
Penicillamine—Neuropathy—Temozolomide—malignant glioma	0.0192	0.0206	CcSEcCtD
Penicillamine—Thrombophlebitis—Carmustine—malignant glioma	0.0178	0.019	CcSEcCtD
Penicillamine—Thrombophlebitis—Temozolomide—malignant glioma	0.0172	0.0184	CcSEcCtD
Penicillamine—Blood alkaline phosphatase increased—Temozolomide—malignant glioma	0.0171	0.0183	CcSEcCtD
Penicillamine—Injury—Carmustine—malignant glioma	0.0167	0.0179	CcSEcCtD
Penicillamine—Hepatic failure—Temozolomide—malignant glioma	0.0165	0.0177	CcSEcCtD
Penicillamine—Dermatitis exfoliative—Temozolomide—malignant glioma	0.0157	0.0169	CcSEcCtD
Penicillamine—Muscular weakness—Carmustine—malignant glioma	0.0136	0.0145	CcSEcCtD
Penicillamine—Toxic epidermal necrolysis—Temozolomide—malignant glioma	0.0134	0.0143	CcSEcCtD
Penicillamine—Muscular weakness—Temozolomide—malignant glioma	0.0131	0.014	CcSEcCtD
Penicillamine—Pancytopenia—Carmustine—malignant glioma	0.0126	0.0135	CcSEcCtD
Penicillamine—Pancytopenia—Temozolomide—malignant glioma	0.0122	0.0131	CcSEcCtD
Penicillamine—Renal failure—Carmustine—malignant glioma	0.0116	0.0125	CcSEcCtD
Penicillamine—Neuropathy peripheral—Carmustine—malignant glioma	0.0116	0.0124	CcSEcCtD
Penicillamine—Stomatitis—Carmustine—malignant glioma	0.0115	0.0124	CcSEcCtD
Penicillamine—Neuropathy peripheral—Temozolomide—malignant glioma	0.0112	0.012	CcSEcCtD
Penicillamine—Stomatitis—Temozolomide—malignant glioma	0.0112	0.012	CcSEcCtD
Penicillamine—Hepatobiliary disease—Temozolomide—malignant glioma	0.0108	0.0116	CcSEcCtD
Penicillamine—Haemoglobin—Carmustine—malignant glioma	0.0107	0.0115	CcSEcCtD
Penicillamine—Haemorrhage—Carmustine—malignant glioma	0.0106	0.0114	CcSEcCtD
Penicillamine—Haemoglobin—Temozolomide—malignant glioma	0.0103	0.0111	CcSEcCtD
Penicillamine—Haemorrhage—Temozolomide—malignant glioma	0.0103	0.011	CcSEcCtD
Penicillamine—Urinary tract disorder—Temozolomide—malignant glioma	0.0102	0.0109	CcSEcCtD
Penicillamine—Urethral disorder—Temozolomide—malignant glioma	0.0101	0.0108	CcSEcCtD
Penicillamine—Tinnitus—Temozolomide—malignant glioma	0.00958	0.0103	CcSEcCtD
Penicillamine—Alopecia—Carmustine—malignant glioma	0.0094	0.0101	CcSEcCtD
Penicillamine—Angiopathy—Temozolomide—malignant glioma	0.00933	0.00999	CcSEcCtD
Penicillamine—Mental disorder—Carmustine—malignant glioma	0.00932	0.00999	CcSEcCtD
Penicillamine—Alopecia—Temozolomide—malignant glioma	0.00908	0.00973	CcSEcCtD
Penicillamine—Mental disorder—Temozolomide—malignant glioma	0.00901	0.00965	CcSEcCtD
Penicillamine—Dysgeusia—Temozolomide—malignant glioma	0.00876	0.00939	CcSEcCtD
Penicillamine—Anaemia—Carmustine—malignant glioma	0.00856	0.00917	CcSEcCtD
Penicillamine—Agitation—Carmustine—malignant glioma	0.00851	0.00912	CcSEcCtD
Penicillamine—Leukopenia—Carmustine—malignant glioma	0.00829	0.00888	CcSEcCtD
Penicillamine—Anaemia—Temozolomide—malignant glioma	0.00827	0.00886	CcSEcCtD
Penicillamine—Agitation—Temozolomide—malignant glioma	0.00822	0.00881	CcSEcCtD
Penicillamine—Leukopenia—Temozolomide—malignant glioma	0.00801	0.00858	CcSEcCtD
Penicillamine—Anxiety—Carmustine—malignant glioma	0.00786	0.00842	CcSEcCtD
Penicillamine—Arthralgia—Temozolomide—malignant glioma	0.00762	0.00816	CcSEcCtD
Penicillamine—Anxiety—Temozolomide—malignant glioma	0.00759	0.00813	CcSEcCtD
Penicillamine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.00757	0.00811	CcSEcCtD
Penicillamine—Thrombocytopenia—Carmustine—malignant glioma	0.0074	0.00793	CcSEcCtD
Penicillamine—Anorexia—Carmustine—malignant glioma	0.0072	0.00772	CcSEcCtD
Penicillamine—Thrombocytopenia—Temozolomide—malignant glioma	0.00715	0.00766	CcSEcCtD
Penicillamine—Skin disorder—Temozolomide—malignant glioma	0.00709	0.0076	CcSEcCtD
Penicillamine—Anorexia—Temozolomide—malignant glioma	0.00696	0.00746	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00688	0.00738	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.00665	0.00713	CcSEcCtD
Penicillamine—Decreased appetite—Carmustine—malignant glioma	0.00657	0.00704	CcSEcCtD
Penicillamine—Decreased appetite—Temozolomide—malignant glioma	0.00635	0.0068	CcSEcCtD
Penicillamine—Body temperature increased—Carmustine—malignant glioma	0.00597	0.0064	CcSEcCtD
Penicillamine—Urticaria—Temozolomide—malignant glioma	0.0058	0.00622	CcSEcCtD
Penicillamine—Body temperature increased—Temozolomide—malignant glioma	0.00577	0.00619	CcSEcCtD
Penicillamine—Hypersensitivity—Carmustine—malignant glioma	0.00557	0.00597	CcSEcCtD
Penicillamine—Hypersensitivity—Temozolomide—malignant glioma	0.00538	0.00577	CcSEcCtD
Penicillamine—Diarrhoea—Carmustine—malignant glioma	0.00517	0.00554	CcSEcCtD
Penicillamine—Diarrhoea—Temozolomide—malignant glioma	0.005	0.00535	CcSEcCtD
Penicillamine—Vomiting—Carmustine—malignant glioma	0.0048	0.00515	CcSEcCtD
Penicillamine—Rash—Carmustine—malignant glioma	0.00476	0.00511	CcSEcCtD
Penicillamine—Dermatitis—Carmustine—malignant glioma	0.00476	0.0051	CcSEcCtD
Penicillamine—Vomiting—Temozolomide—malignant glioma	0.00464	0.00498	CcSEcCtD
Penicillamine—Rash—Temozolomide—malignant glioma	0.0046	0.00493	CcSEcCtD
Penicillamine—Dermatitis—Temozolomide—malignant glioma	0.0046	0.00493	CcSEcCtD
Penicillamine—Nausea—Carmustine—malignant glioma	0.00449	0.00481	CcSEcCtD
Penicillamine—Nausea—Temozolomide—malignant glioma	0.00434	0.00465	CcSEcCtD
